美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Inotek Pharmaceuticals Corporation

3.04

+0.0000

成交量：- -

成交额：- -

市值：8,211.04万

市盈率：-1.99

高：3.04

开：3.04

低：3.04

收：3.04

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Inotek Pharmaceuticals Corporation

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.inotekpharma.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Inotek制药公司是于1999年7月7日根据美国特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于治疗青光眼药物的发现，开发和商业化。该公司领先的候选产品，trabodenoson，是一级可选择的腺苷模拟，腺苷模拟是该公司通过恢复眼睛的自然压力控制机制来降低眼压机制。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ITEK/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ITEK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ITEK\",,,,,undefined,":{"symbol":"ITEK","market":"US","secType":"STK","nameCN":"Inotek Pharmaceuticals Corporation","latestPrice":3.04,"timestamp":1515099600000,"preClose":3.04,"halted":4,"volume":0,"delay":0,"floatShares":12060000,"shares":27010000,"eps":-1.53,"marketStatus":"退市","change":0,"latestTime":"04-29 13:21:38 EDT","open":3.04,"high":3.04,"low":3.04,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.53,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745956800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.04,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ITEK\",,,,,undefined,":{"symbol":"ITEK","floatShares":12060000,"roa":"--","roe":"--","lyrEps":0,"shares":27010000,"dividePrice":0,"high":3.04,"amplitude":0,"preClose":3.04,"low":3.04,"week52Low":0.85,"pbRate":"1.43","week52High":3.8,"institutionHeld":0,"latestPrice":3.04,"eps":-1.53,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.53,"open":3.04},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.inotekpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inotek制药公司是于1999年7月7日根据美国特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于治疗青光眼药物的发现，开发和商业化。该公司领先的候选产品，trabodenoson，是一级可选择的腺苷模拟，腺苷模拟是该公司通过恢复眼睛的自然压力控制机制来降低眼压机制。","exchange":"NASDAQ","name":"Inotek Pharmaceuticals Corporation","nameEN":"Inotek Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ITEK\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ITEK\",params:#limit:5,,,undefined,":[{"date":"2018-01-05","symbol":"ITEK","newSymbol":"RCKT","type":"symbolChange","dateTimestamp":1515128400000},{"market":"US","date":"2017-12-27","symbol":"ITEK","name":"Inotek Pharmaceuticals Corporation","time":"","type":"earning","dateTimestamp":1514350800000,"reportTimeType":""},{"market":"US","date":"2017-08-03","symbol":"ITEK","fiscalQuarterEnding":"2017/06","expectedEps":-0.54,"name":null,"time":"","type":"earning","dateTimestamp":1501732800000,"reportTimeType":"","actualEps":-0.24},{"market":"US","date":"2017-05-10","symbol":"ITEK","fiscalQuarterEnding":"2017/03","expectedEps":-0.35,"name":null,"time":"","type":"earning","dateTimestamp":1494388800000,"reportTimeType":"","actualEps":-0.4},{"market":"US","date":"2017-03-16","symbol":"ITEK","fiscalQuarterEnding":"2016/12","expectedEps":-0.39,"name":null,"time":"","type":"earning","dateTimestamp":1489636800000,"reportTimeType":"","actualEps":-0.48}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ITEK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ITEK\",market:\"US\",delay:false,,,undefined,":{}}}